Next Quarterly Earnings
Tuesday, November 10, 2026
CW 46
Pre-Market
In 75 days
Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
Cogent Biosciences
Cogent Biosciences is a US-based biotechnology company specializing in the development of innovative precision medicines for genetically defined cancers. The firm focuses on researching kinase inhibitors to create targeted cancer therapies designed to address the needs of patients with high unmet requirements.
Frequently asked questions
When will Cogent Biosciences report its next quarterly earnings?
Cogent Biosciences is scheduled to report its next quarterly earnings on 11/10/2026. Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
When did Cogent Biosciences last report quarterly earnings?
Cogent Biosciences last reported quarterly earnings on 8/10/2026 (Q2 2026). Earnings per share (EPS) came in at -0.52 USD.
How often has Cogent Biosciences beaten expectations?
Cogent Biosciences has beaten analyst EPS estimates in 4 of its last 5 evaluated quarters (beat rate: 80%).
How do I add the Cogent Biosciences earnings dates to my calendar?
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
All Dates
Earnings statistics
Estimates vs. results
4/5
Quarters above estimates
80%
Beat rate
+1.4%
Avg. EPS surprise
Basis: 5 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.
Company Information
Name
Cogent Biosciences
Country
🇺🇸
More Financial Information